Makary's 'Conditional Approval' Pathway for Rare Diseases Poses More Questions Than Answers

Retrieved on: 2025-05-19 04:07:47

Tags for this article:

Click the tags to see associated articles and topics

Makary's 'Conditional Approval' Pathway for Rare Diseases Poses More Questions Than Answers. View article details on hiswai:

Excerpt

While sparking excitement among biopharma companies focused on rare and ultrarare indications, experts say FDA Commissioner Marty Makary's ...

Article found on: www.biospace.com